Codexis, Inc.

Healthcare · Biotechnology · United States

Last price 1.19 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 130.31M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The co...